Both in Pharmaceuticals
MBX Biosciences vs Palvella Therapeutics
Over the past year MBX returned +154.5% and PVLA returned +116.2%; their daily moves had a correlation of 0.38.
MBX +154.5% PVLA +116.2%Growth of $1, one year, split-adjusted
| Metric | MBX | PVLA |
|---|---|---|
| Price | $52.48 | $162.28 |
| Market cap | $2.53B | $2.34B |
| Today | −4.58% | +6.11% |
| 1 month | −7.8% | +26.8% |
| 6 months | +63.4% | +24.7% |
| Year to date | +66.4% | +55.0% |
| 1 year | +154.6% | +111.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $250.6M |
| Dividend yield | — | — |
| Volatility (60d) | 48.5% | 48.6% |
| Short % of float | 15.0% | 21.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).